ACORN BIOVENTURES, L.P. - 22 Dec 2025 SCHEDULE 13G Report for Athira Pharma, Inc. Common Stock, $0.0001 Par Value (ATHA)

Filing Manager
ACORN BIOVENTURES, L.P.
Reporting Manager
Anders Hove
Security
Athira Pharma, Inc. Common Stock, $0.0001 Par Value
Symbol
ATHA
Shares outstanding
9.65M shares
Disclosed Ownership
502K shares
Ownership
5.2%
Form type
SCHEDULE 13G
Filing time
23 Dec 2025, 16:46:14 UTC
Date of event
22 Dec 2025
SEC
View on sec.gov

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
ACORN BIOVENTURES, L.P. 2.2% 211K 0 211K Anders Hove Manager of General Partner
ACORN CAPITAL ADVISORS GP, LLC 2.2% 211K 0 211K Anders Hove Manager
ACORN BIOVENTURES 2, L.P. 3% 291K 0 291K Anders Hove Manger of General Partner
Acorn Capital Advisors GP 2, LLC 3% 291K 0 291K Anders Hove Manager
Anders Hove 5.2% 502K 0 502K Anders Hove Individually